Spectral AI is trading at $1.80, up 6.51%, with broad-market gains potentially contributing.

  • Supplied market context shows the S&P 500, Nasdaq Composite, and Dow up more than 0.5%.
  • On October 6, Spectral AI announced submitting a CMS NTAP reimbursement application for its DeepView System; a decision is expected in August 2027, and approval has not been granted.
  • The application is a potential reimbursement pathway; no explicit stock-price linkage was reported, and the announcement does not establish it caused the share move.